How I manage pulmonary Langerhans cell histiocytosis
Authors:
Open Access
- 6 September 2017
- journal article
- case report
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 26 (145) , 170070
Abstract
Pulmonary Langerhans cell histiocytosis (PLCH) is a rare sporadic cystic lung disease of unknown aetiology that is characterised by the infiltration and destruction of the wall of distal bronchioles by CD1a+Langerhans-like cells. In adults, PLCH is frequently isolated and affects young smokers of both sexes. Recent multicentre studies have led to the more standardised management of patients in clinical practice. Smoking cessation is essential and is occasionally the only suitable intervention. Serial lung function testing is important because a significant proportion of patients may experience an early decline in forced expiratory volume in 1 s and develop airflow obstruction. Cladribine was reported to dramatically improve progressive PLCH in some patients. Its efficacy and tolerance are currently being evaluated. Patients who complain of unexplained dyspnoea with decreased diffusing capacity of the lung for carbon monoxide should be screened for pulmonary hypertension by Doppler echocardiography, which must be confirmed by right heart catheterisation. Lung transplantation is a therapeutic option for patients with advanced PLCH.The identification of theBRAFV600Emutation in approximately half of Langerhans cell histiocytosis lesions, including PLCH, and other mutations of the mitogen-activated protein kinase (MAPK) pathway in a subset of lesions has led to targeted treatments (BRAF and MEK (MAPK kinase) inhibitors). These treatments need to be rigorously evaluated because of their potentially severe side-effects.Keywords
This publication has 101 references indexed in Scilit:
- Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-NetOrphanet Journal of Rare Diseases, 2013
- Pulmonary langerhans cell histiocytosisOrphanet Journal of Rare Diseases, 2012
- BRAFMutations in Hairy-Cell LeukemiaNew England Journal of Medicine, 2011
- Recurrent BRAF mutations in Langerhans cell histiocytosisBlood, 2010
- Cigarette smoke promotes dendritic cell accumulation in COPD; a Lung Tissue Research Consortium studyRespiratory Research, 2010
- Selective accumulation of langerhans-type dendritic cells in small airways of patients with COPDRespiratory Research, 2010
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)European Heart Journal, 2009
- Herpes-Virus Infection in Patients with Langerhans Cell Histiocytosis: A Case-Controlled Sero-Epidemiological Study, and In Situ AnalysisPLOS ONE, 2008
- Expansion of Regulatory T Cells in Patients with Langerhans Cell HistiocytosisPLOS Medicine, 2007
- Mutations of the BRAF gene in human cancerNature, 2002